Victoria P. Werth

faculty photo
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Division Of Dermatology, University of Pennsylvania Health System (to include the Hospital of the University of Pennsylvania and Presbyterian Hospital)
Department: Dermatology

Contact information
Division of Dermatology
Veterans Administration Hospital
University and Woodland Avenues
Philadelphia, PA 19104
Office: 215-823-4208
Fax: 215-823-5171
BA (Chemistry)
Catholic University, 1976.
MS (Physical Chemistry)
Catholic University, 1976.
M.D. (Medicine)
Johns Hopkins University, 1980.
Permanent link

Description of Research Expertise

Tumor necrosis factor
Cutaneous lupus
Clinical and translational research in cutaneous autoimmune diseases

Description of Itmat Expertise

Dr. Werth's research is in the area of autoimmune skin diseases, with a focus on cutaneous lupus erythematosus, dermatomyositis, and pemphigus.

Selected Publications

Weinstock MA, Thwin SS, Siegel, JA, …Werth VP, …Huang GD: Chemoprevention of basal and squamous cell carcinoma with a single course of 5-fluorouracil 5% cream: A Veterans Affairs randomized controlled trial. JAMA Dermatol 154(2): 167-174, 2018.

Concha JSS, Merola JF, Fiorentino D, Werth VP: Reexamining mechanic’s hands as a characteristic skin finding in dermatomyositis. J Am Acad Dermatol 17(32592-6), November 2017.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC: Dermatological Addendum to the 2012 International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol 10(1002), November 2017.

Chansky PB, Olazagasti JM, Feng R, Werth VP. : Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI). J Am Acad Dermatol 17(32578), October 2017.

Kim HJ, Langenhan JL, Robinson ES, Privette E, Achtman JC, Mitrani RA, Zeidi M, Sharma MR, Feng R, Nevas JL, Calianno C, Okawa J, Taylor L, Pappas-Taffer L, Werth VP. : Effect of Long-term Treatment with TNFα Inhibitors on Single-dose UV-induced Changes in Human Skin. Br J Dermatol doi: 10.1111/bjd.15897, August 2017.

Szczęch J, Samotij D, Werth VP, Reich A: Trigger factors of cutaneous lupus erythematosus: a review of current literature. Lupus 26(8)(791-807), July 2017.

Pomerantz H, Chren MM, Lew R, Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*. : Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial. Clin Exp Dermatol 4295)(488-495), July 2017.

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J: International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology... Arthritis Rheumatol 69(5)(898-910), May 2017.

Mittal L, Werth VP: The quinacrine experience in a population of cutaneous lupus erythematousus and dermatomyositis patients. J Am Acad Dermatol 77(374-377), 2017.

Chansky PB, Werth VP: Accidental hydroxychloroquine overdose resulting in neurotoxic vestibulopathy. BMJ Case Rep 10(1136/bcr-2016-218786. ), 2017.

back to top
Last updated: 09/05/2018
The Trustees of the University of Pennsylvania